Hexarelin

Made in the USA from imported peptide APIs (purified, filled and lyophilized domestically) and independently third-party tested. A Certificate of Analysis is published for every shipped lot, look yours up with our COA verification tool.

Hexarelin (Examorelin) Synthetic Growth Hormone Secretagogue Hexapeptide | Research Use Only

Hexarelin is a synthetic hexapeptide and growth hormone secretagogue (GHS) developed as a structural analogue of GHRP-6, with modifications conferring enhanced receptor binding affinity. It acts as an agonist at the growth hormone secretagogue receptor (GHSR-1a), also known as the ghrelin receptor, and has been extensively utilized in preclinical research examining the GH/IGF-1 axis.

In laboratory and animal model studies, Hexarelin has been investigated for its role in growth hormone release mechanisms, pituitary function studies, and hypothalamic-pituitary signaling pathways. It has been widely utilized in cardiovascular biology research, with studies examining its interactions with CD36 receptors in cardiac tissue models and cardioprotective signaling pathways. Additional research applications include investigations of muscle biology, protein synthesis mechanisms, appetite regulation models, and metabolic signaling studies.

Research Specifications:

Available in Single 10MG vials or 10 Packs

• Sequence: His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH₂
• Molecular Formula: C₄₇H₅₈N₁₂O₆
• Molecular Weight: 887.05 g/mol
• CAS Number: 140703-51-1
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Storage: -20°C, protected from light and moisture

For Research Use Only. This product is not intended for human or veterinary use, diagnosis, or treatment. Not evaluated by the FDA. For qualified research applications only.

Chemical identity & references
PubChem CID 6918297 · CAS 140703-51-1 · C47H58N12O6, 887.0 g/mol

Molecular weights shown are nominal identity values; salt or complex form and net peptide content are stated on each lot’s Certificate of Analysis. Verify this lot’s COA.